Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI), a biopharmaceutical company specializing in central nervous system (CNS) disorder treatments, has announced a conference call and webcast for August 7, 2024, at 8:30 a.m. Eastern Time. The event will provide a corporate update and discuss financial results for the quarter ending June 30, 2024.

Participants can join the call via phone by using the provided registration link. The webcast will be accessible through the company's website under the Investor Relations section. Interested parties are advised to log in 5-10 minutes early to complete the registration process and install any necessary software.

News Market Reaction – ITCI

-1.19%

-1.19% Session move

In the trading session that priced this news, ITCI declined 1.19%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Wednesday, August 7, 2024, to provide a corporate update and discuss details of the Company's financial results for the quarter ended June 30, 2024.

To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406

FAQ

When is Intra-Cellular Therapies (ITCI) hosting its Q2 2024 earnings call?

Intra-Cellular Therapies (ITCI) is hosting its Q2 2024 earnings call on Wednesday, August 7, 2024, at 8:30 a.m. Eastern Time.

How can investors access ITCI's Q2 2024 financial results conference call?

Investors can access ITCI's Q2 2024 financial results conference call by phone using the registration link provided by the company, or via live webcast on the company's website under the Investor Relations section.

What will be discussed during ITCI's Q2 2024 earnings call?

ITCI's Q2 2024 earnings call will provide a corporate update and discuss the company's financial results for the quarter ended June 30, 2024.

Where can I find the webcast for ITCI's Q2 2024 earnings call?

The webcast for ITCI's Q2 2024 earnings call can be accessed under 'Events & Presentations' in the Investor Relations section of the company's website at www.intracellulartherapies.com.